|
1
|
Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer.
|
J Magn Reson Imaging
|
2002
|
2.64
|
|
2
|
Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy.
|
Radiology
|
2004
|
1.69
|
|
3
|
Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues.
|
Magn Reson Med
|
2008
|
1.69
|
|
4
|
Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging.
|
Radiology
|
2002
|
1.68
|
|
5
|
Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system.
|
Radiology
|
2004
|
1.58
|
|
6
|
Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience.
|
Radiology
|
2004
|
1.36
|
|
7
|
Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells.
|
J Biol Chem
|
2003
|
1.31
|
|
8
|
Evaluation of the ERETIC method as an improved quantitative reference for 1H HR-MAS spectroscopy of prostate tissue.
|
Magn Reson Med
|
2009
|
1.18
|
|
9
|
Characterization of intervertebral disc degeneration by high-resolution magic angle spinning (HR-MAS) spectroscopy.
|
Magn Reson Med
|
2005
|
1.08
|
|
10
|
Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR-MAS spectroscopy.
|
NMR Biomed
|
2009
|
1.05
|
|
11
|
Quantification of prostate MRSI data by model-based time domain fitting and frequency domain analysis.
|
NMR Biomed
|
2006
|
1.05
|
|
12
|
Improved signal to noise in high-resolution magic angle spinning total correlation spectroscopy studies of prostate tissues using rotor-synchronized adiabatic pulses.
|
Magn Reson Med
|
2005
|
1.01
|
|
13
|
Human prostate cancer ZIP1/zinc/citrate genetic/metabolic relationship in the TRAMP prostate cancer animal model.
|
Cancer Biol Ther
|
2011
|
0.90
|
|
14
|
Feasibility of magnetic resonance spectroscopy for evaluating fetal lung maturity.
|
J Pediatr Surg
|
2006
|
0.82
|
|
15
|
Calculation of gestational age in late second and third trimesters by ex vivo magnetic resonance spectroscopy of amniotic fluid.
|
Am J Obstet Gynecol
|
2010
|
0.81
|
|
16
|
Magnetic resonance spectroscopy in patients with locally confined prostate cancer: association of prostatic citrate and metabolic atrophy with time on hormone deprivation therapy, PSA level, and biopsy Gleason score.
|
Eur Radiol
|
2006
|
0.81
|
|
17
|
Quantitative metabolic profiles of 2nd and 3rd trimester human amniotic fluid using (1)H HR-MAS spectroscopy.
|
MAGMA
|
2009
|
0.81
|
|
18
|
(1)H HR-MAS spectroscopy for quantitative measurement of choline concentration in amniotic fluid as a marker of fetal lung maturity: inter- and intraobserver reproducibility study.
|
J Magn Reson Imaging
|
2008
|
0.79
|